VioQuest Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug therapies for the molecular basis of cancer and side effects of cancer treatment. The company is headquartered in Basking Ridge, New Jersey and currently employs 3 full-time employees. The Company’s lead compound under development is Xyfid (1% topical uracil) for the treatment and prevention of Hand-Foot Syndrome (HFS). In parallel, Xyfid is also being developed to treat dry skin conditions and manage the burning and itching associated with various diseases of the skin or dermatoses. In addition, VioQuest Pharmaceuticals is developing VQD-002 (triciribine phosphate monohydrate or TCN-P), a small molecule anticancer compound that inhibits activation of protein kinase B (PKB or AKT), a key component of a signaling pathway known to promote cancer cell growth and survival, as well as resistance to chemotherapy and radiotherapy. On July 16, 2007, the Company completed the sale of Chiral Quest, Inc. to Chiral Quest Acquisition Corp.
VOQP stock price ended at $0 on Friday, after rising NaN%
On the latest trading day Mar 27, 2026, the stock price of VOQP rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by -- shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 100 shares were traded, equating to a market value of approximately --.
VOQP Technical Signals
Technical Signals Summary
Buy Signals 0
Neutral Signals 6
Sell Signals 1
Strong Sell
Sell
Neutral
Buy
Strong Buy
VOQP currently exhibits 0 buy signals and 1 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of -- during this period. Overall, the technical indicators point to a Sell outlook for the mid-term.
Bullish/Bearish Signals for VOQP
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for VOQP. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to VOQP?
According to technical analysis, Vioquest Pharmaceuticals Inc has an aggregate signal of Sell. Vioquest Pharmaceuticals Inc has 0 Buy signals, 6 Neutral Signals and 1 sell signals.
What are the Fibonacci retracement levels for VOQP?
The Fibonacci retracement level for Vioquest Pharmaceuticals Inc is between 78.6% and 100%
What is the RSI for Vioquest Pharmaceuticals Inc?
The RSI for Vioquest Pharmaceuticals Inc is currently 100.00, indicating a overbought condition
What is Vioquest Pharmaceuticals Inc price for the next 12 months?
Vioquest Pharmaceuticals Inc VOQP price for the next 12 months is estimated at $0.
How high is Vioquest Pharmaceuticals Inc expected to go?
According to wall street analysts, Vioquest Pharmaceuticals Inc is expected to reach a high forecast of $0.